Director - Translational Research
Bristol Myers Squibb
Dr. Martin is a Director, Translational Research within the Cancer Immunology and Cell Therapy Thematic Research Center at BMS, where he leads a team driving the translational biomarker activities for T cell redirection therapies in multiple myeloma. Nathan has previously held translational research positions at BioMarin Pharmaceuticals and Flagship Biosciences, and received his PhD from the University of California – Los Angeles.